Example: Heart Attack

Search clinical trials for: Maleic acid

Total 342 results

NCT03842631

Recruiting

Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination

Conditions: Infantile Hemangioma
NCT04293081

Completed

Preemptive Chlorepheniramine Maleate Reducing Postoperative Agitation

Conditions: Agitated; State, Acute Reaction to Stress
NCT04486911

Not yet recruiting

Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial

Conditions: Breast Cancer
NCT03667131

Completed

Enalapril Maleate on Arterial Stiffness in Rheumatoid Arthritis.

Conditions: Rheumatoid Arthritis
NCT01806376

Unknown status

A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics

Conditions: Solid Tumor
NCT03109886

Unknown status

Study of Milciclib in Patients With Unresectable/Metastatic Hepatocellular Carcinoma

Conditions: Hepatocellular Carcinoma
NCT03856697

Not yet recruiting

Abivertinib Maleate Versus Geifitinib in Patients With Advanced Non-small Cell Lung Cancer With Sensitive EGFR Mutation

Conditions: Advanced Non-small Cell Lung Cancer
NCT01984931

Unknown status

Study of Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)for Treatment of Post Operative Nausea and Vomiting

Conditions: Nausea; Vomiting
NCT02986685

Unknown status

Trimebutine Maleate Combined With Rabeprazole in Patients With Grade A or B Reflux Esophagitis Whose Symptoms Refractory to Rabeprazole

Conditions: Refractory Reflux Esophagitis
NCT01132820

Completed

Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Conditions: Endometrial Adenocarcinoma; Endometrial Adenosquamous Carcinoma; Endometrial Clear Cell Adenocarcinoma; Endometrial Serous Adenocarcinoma; Recurrent Uterine Corpus Carcinoma
NCT03876587

Not yet recruiting

Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC

Conditions: Metastatic Breast Cancer
NCT00605306

Completed

Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma

Conditions: Asthma
NCT01752049

Completed

Topical Anti-angiogenic Therapy for Telangiectasia in HHT: Proof of Concept

Conditions: Hereditary Hemorrhagic Telangiectasia
NCT00894634

Completed

Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents

Conditions: Allergic Reactions
NCT01607671

Withdrawn

Treatment Study for Ischemic Optic Neuropathy With Opthalmic Timolol Maleate 0.5%

Conditions: Optic Neuropathy, Ischemic; Anterior Ischemic Optic Neuropathy; Ischemic Optic Neuropathy; Optic Neuropathy, Anterior Ischemic
NCT01377051

Completed

Effect of Indacaterol Maleate in Chronic Obstructive Pulmonary Disease (COPD) on Lung Volume and Related Dyspnea

Conditions: COPD; Lung Diseases; Dyspnea; Hypoxemia; Tachycardia
NCT01871740

Withdrawn

CSPPT- Chronic Kidney Diseases Study

Conditions: Hypertension; Hyperhomocysteinemia
NCT00979862

Completed

Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma

Conditions: Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Recurrent Adult Brain Neoplasm
NCT04528667

Not yet recruiting

Study of the Safety and Efficacy of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized Due to COVID-19

Conditions: Covid19
NCT00624702

Completed

Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma

Conditions: Asthma
NCT04440007

Recruiting

Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19

Conditions: Covid-19
NCT03544229

Recruiting

A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis

Conditions: Diabetic Gastroparesis; Idiopathic Gastroparesis
NCT03691662

Active, not recruiting

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study

Conditions: Glaucoma and Ocular Hypertension
NCT03691649

Active, not recruiting

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study

Conditions: Glaucoma and Ocular Hypertension
NCT04315493

Not yet recruiting

Effect of Low-fat Diet on the Pharmacokinetics of Pyrotinib in Healthy Participants

Conditions: Healthy Participants